A new positron emission tomography radiotracer has the potential to spot signs of Alzheimer’s disease years before symptoms appear.
That’s according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, which wraps up on Tuesday, June 15. The chemical compound 18F-MK6240 has been shown to effectively measure increases in brain tau, a protein commonly found in healthy brain neurons.
Scientists see potential in using the new tracer to test the impact of emerging Alzheimer’s therapies. Read More